Results 11 to 20 of about 43,470 (269)

Primary antiphospholipid syndrome associated with anti-phospholipase A2 receptor antibody-positive membranous nephropathy

open access: yesBMC Nephrology, 2020
Background The kidney is a major target in primary antiphospholipid syndrome. Several types of nephropathy have been reported, the most frequent being acute or chronic specific vascular nephropathies and membranous nephropathy.
Maxime Teisseyre   +6 more
doaj   +1 more source

Prognostic significance of concentric left ventricular hypertrophy at peritoneal dialysis initiation

open access: yesBMC Nephrology, 2021
Background Concentric left ventricular hypertrophy (cLVH) is a common left ventricular geometric pattern in patients undergoing maintenance dialysis, including peritoneal dialysis (PD).
Misato Tomura   +8 more
doaj   +1 more source

Tocilizumab and Active Antibody-Mediated Rejection in Kidney Transplantation: A Literature Review

open access: yesFrontiers in Immunology, 2022
IntroductionChronic kidney disease (CKD) is a major public-health problem that increases the risk of end-stage kidney disease (ESKD), cardiovascular diseases, and other complications.
Lara Cabezas   +10 more
doaj   +1 more source

The 1(st) and the 2(nd) Italian Consensus Conferences on low-density lipoprotein-apheresis. A practical synopsis and update [PDF]

open access: yes, 2016
The clinical indications and guidelines for low-density lipoprotein (LDL)-apheresis set by the 1(st) Italian Consensus Conference held in Ostuni in 1990 and completed in 1992, but never published, are reported schematically.
Stefanutti, Claudia
core   +1 more source

Efficacy of Plasmapheresis in Nivolumab-Associated ANCA Glomerulonephritis: A Case Report and Pathophysiology Discussion

open access: yesCase Reports in Nephrology and Dialysis, 2021
Immune checkpoint inhibitors (ICIs) have revolutionized solid organ and hematologic cancer treatments by improving overall prognoses. However, they can lead to overactivation of the immune system and several immune-related adverse events and sometimes ...
Reda Laamech   +7 more
doaj   +1 more source

Study on the production efficiency of platelet components in 24 prefecture-level blood stations in China

open access: yesZhongguo shuxue zazhi, 2022
Objective To learn the production efficient of platelet components among prefecture-level blood stations in China, to provide supporting data for those blood stations to optimize the production mode of platelet components and continuously improve ...
Minyu HUA   +25 more
doaj   +1 more source

International forum. an investigation of iron status in blood donors [PDF]

open access: yes, 2017
No abstract ...
Anderson, Nicky   +35 more
core   +1 more source

Red Blood Cell Transfusions in Greece: Results of a Survey of Red Blood Cell Use in 2013

open access: yesTurkish Journal of Hematology, 2017
Objective: Greece is ranked as the second highest consumer of blood components in Europe. For an effective transfusion system and in order to reduce variability of transfusion practice by implementing evidence-based transfusion guidelines it is necessary
Serena Valsami   +19 more
doaj   +1 more source

Relationship between Sustained Reductions in Plasma Lipid and Lipoprotein Concentrations with Apheresis and Plasma Levels and mRNA Expression of PTX3 and Plasma Levels of hsCRP in Patients with HyperLp(a)lipoproteinemia [PDF]

open access: yes, 2016
The effect of lipoprotein apheresis (Direct Adsorption of Lipids, DALI) (LA) on plasma levels of pentraxin 3 (PTX3), an inflammatory marker that reflects coronary plaque vulnerability, and expression of PTX3 mRNA was evaluated in patients with hyperLp(a ...
De Nève, Joel   +6 more
core   +3 more sources

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma. [PDF]

open access: yes, 2016
Prostate cancer is the most commonly diagnosed malignancy and second leading cause of cancer death among men in the United States. In recent years, several new agents, including cancer immunotherapies, have been approved or are currently being ...
Bander, Neil H   +17 more
core   +1 more source

Home - About - Disclaimer - Privacy